Myelodysplastic Syndrome

Under the direction of Dr. Azra Raza, a team of clinical and basic science researchers experienced in the study and treatment of Myelodysplastic Syndrome (MDS) is working at St. Vincent's to develop more effective therapies. The MDS Program is unique in that the team has built a national referral base for MDS treatment and research with a large enough patient population for meaningful clinical trials. Patients travel from all over the country to receive the latest and most cutting-edge therapies for their MDS, and to participate in molecular and genetic studies of their bone marrows, which sheds more light on their particular form of the disease and allows for individualized therapies.

Leukemia

St. Vincent's Comprehensive Cancer Center offers patients access to a team of experts who specialize in the treatment and research of hematologic malignancies including Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, and Acute Myeloid Leukemia. Clinical trials and support services are available for the benefit of our patients.

The contents of this website are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding symptoms, treatment alternatives and possible risks and benefits. Never disregard or delay seeking professional medical advice based on anything on this website.